Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$311.04 - $363.55 $1.43 Million - $1.67 Million
4,600 Added 15.33%
34,600 $12.4 Million
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $3.74 Million - $5.23 Million
-16,400 Reduced 35.34%
30,000 $9.56 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $9.97 Million - $11.9 Million
46,400 New
46,400 $10.2 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.